DEVELOPMENT OF IRON-CHELATING AGENTS FOR CLINICAL USE

被引：0

作者：

BRITTENHAM, GM ^{[1
]}

机构：

[1] CASE WESTERN RESERVE UNIV,DEPT MED,DIV HEMATOL,CLEVELAND,OH 44106

来源：

BLOOD | 1992年 / 80卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：569 / 574

页数：6

共 50 条

[1] UPDATE ON THE HYDROXYPYRIDINONE ORAL IRON-CHELATING AGENTS
PORTER, JB
HIDER, RC
HUEHNS, ER
SEMINARS IN HEMATOLOGY, 1990, 27 (02) : 95 - 100
[2] EVALUATION OF IRON-CHELATING AGENTS IN AN INVIVO SYSTEM - POTENTIAL USEFULNESS OF EHPG, A POWERFUL IRON-CHELATING DRUG
HERSHKO, C
GRADY, RW
LINK, G
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 251 - 260
[3] ANTIOXIDANT AND IRON-CHELATING AGENTS IN CEREBRAL VASOSPASM
LUO, ZY
HARADA, T
LONDON, S
GAJDUSEK, C
MAYBERG, MR
NEUROSURGERY, 1995, 37 (06) : 1154 - 1158
[4] Synthesis and characterization of novel iron-chelating agents
Edenfield, Emily T.
Whitlock, Christine R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
[5] DEVELOPMENT OF NEW IRON-CHELATING DRUGS
GRADY, RW
GRAZIANO, JH
AKERS, HA
CERAMI, A
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1976, 196 (02): : 478 - 485
[6] IRON-CHELATING AGENTS AND THE REDUCTIVE REMOVAL OF IRON FROM TRANSFERRIN
ANKEL, E
PETERING, DH
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (12) : 1833 - 1837
[7] IRON-CHELATING AGENTS IN NON-IRON OVERLOAD CONDITIONS
VOEST, EE
VREUGDENHIL, G
MARX, JJM
ANNALS OF INTERNAL MEDICINE, 1994, 120 (06) : 490 - 499
[8] ANTIOXIDANT AND IRON-CHELATING AGENTS IN CEREBRAL VASOSPASM - COMMENTS
WEIR, BKA
NEUROSURGERY, 1995, 37 (06) : 1158 - 1158
[9] EFFECT OF IRON-CHELATING AGENTS ON INHIBITORS OF RIBONUCLEOTIDE REDUCTASE
CORY, JG
LASATER, L
SATO, A
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (09) : 979 - 984
[10] IRON-CHELATING AGENTS ARE NOT USEFUL IN TREATING ATHEROSCLEROSIS - REPLY
MARX, JJM
VREUGDENHIL, G
VOEST, EE
ANNALS OF INTERNAL MEDICINE, 1994, 121 (05) : 384 - 385

← 1 2 3 4 5 →